Inflammatory Links Between Hypertriglyceridemia and Atherogenesis Xueying PengHuaizhu Wu Vascular Biology (H. Pownall, Section Editor) 11 March 2022 Pages: 297 - 306
RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases Nada BejarTrinh T. TatDaniel L. Kiss Vascular Biology (H. Pownall, Section Editor) 02 April 2022 Pages: 307 - 321
Free Cholesterol Bioavailability and Atherosclerosis Rei J. AbeJun-ichi AbeNhat-Tu Le Vascular Biology (H. Pownall, Section Editor) Open access 25 March 2022 Pages: 323 - 336
Coronary Artery Calcium for Risk Assessment in Young Adults Ayman HaqMichael D. Miedema Evidence‐Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 10 March 2022 Pages: 337 - 342
Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations Ian K. EverittKatherine V. TrinhSadiya S. Khan Evidence‐Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 02 March 2022 Pages: 343 - 356
PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology Tereza AltschmiedováVeronika TodorovováRichard Češka Statin Drugs (R. Ceska, Section Editor) 25 March 2022 Pages: 357 - 363
The Role of High-Density Lipoprotein Cholesterol in 2022 Cesare R. SirtoriAlberto CorsiniMassimiliano Ruscica Statin Drugs (R. Ceska, Section Editor) Open access 10 March 2022 Pages: 365 - 377
The Role of Non-statin Lipid-Lowering Medications in Youth with Hypercholesterolemia Waleed Z. ButtJennifer K. Yee Children/Adolescents/Young Adults and Atherosclerosis (D.P. Wilson, Section Editor) 28 March 2022 Pages: 379 - 389
Saturated Fat and Cardiovascular Health: Phenotype and Dietary Factors Influencing Interindividual Responsiveness Xiaoran LiuScott V. HardingTodd C. Rideout Nutrition (K. Petersen, Section Editor) 23 March 2022 Pages: 391 - 398
